Which antidepressant is more appropriate for my depression: Wellbutrin (bupropion) or Lexapro (escitalopram)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Wellbutrin vs Lexapro for Depression

For most patients with major depression, choose either medication based on side effect profile: select Wellbutrin (bupropion) if sexual dysfunction, weight gain, or sedation are concerns; select Lexapro (escitalopram) if insomnia, seizure risk, or uncontrolled hypertension are concerns—both are equally effective for treating depression. 1, 2

Equal Efficacy Between Medications

The American College of Physicians guidelines establish that no second-generation antidepressant demonstrates superior efficacy over another for treating major depressive disorder 1. Multiple head-to-head trials confirm bupropion and escitalopram produce equivalent:

  • Response rates (approximately 70% for both)
  • Remission rates (approximately 40-47%)
  • Reduction in depression severity scores 3, 4, 5

This equivalence holds across patient subgroups including age, sex, race, and comorbid conditions 1.

Decision Algorithm Based on Side Effects

Choose Wellbutrin (Bupropion) When:

Sexual function is a priority:

  • Bupropion has significantly lower rates of sexual dysfunction than escitalopram (and other SSRIs) 1, 6
  • This represents the most clinically meaningful difference between these medications

Weight management matters:

  • Bupropion causes less weight gain than SSRIs 1
  • May even facilitate weight loss in some patients 7

Patient has comorbid conditions:

  • Smoking cessation needed: Bupropion is FDA-approved for this indication 7
  • Obesity with depression: Consider naltrexone-bupropion combination 7
  • ADHD symptoms present: Bupropion may provide dual benefit 8

Avoiding sedation:

  • Bupropion is activating rather than sedating 1

Choose Lexapro (Escitalopram) When:

Anxiety symptoms predominate:

  • SSRIs like escitalopram are preferred for depression with significant anxiety 9
  • Bupropion's stimulating properties can worsen anxiety in some patients 9

Seizure risk exists:

  • Bupropion lowers seizure threshold and should be avoided in patients with epilepsy or seizure history 1, 10

Uncontrolled hypertension present:

  • Bupropion can increase blood pressure 7

Insomnia is problematic:

  • Bupropion is activating and may worsen insomnia 7
  • Escitalopram is less likely to cause insomnia

Older adults (≥65 years):

  • Escitalopram is specifically recommended for elderly patients 2

Critical Safety Considerations

Both Medications:

  • Monitor for suicidal thoughts/behaviors, especially in patients <24 years old, during first 1-2 weeks and at dose changes 10
  • SSRIs (including escitalopram) carry increased risk of nonfatal suicide attempts compared to placebo 1
  • Assess response within 1-2 weeks of initiation 1

Bupropion-Specific:

  • Contraindicated in patients with seizure disorders or eating disorders 1
  • Avoid with MAOIs or within 14 days of MAOI use
  • Use caution with conditions increasing seizure risk

Escitalopram-Specific:

  • Risk of serotonin syndrome, especially with other serotonergic drugs 10
  • Contraindicated with MAOIs or pimozide 10
  • Taper gradually when discontinuing to avoid discontinuation syndrome 10

Dosing Considerations

Bupropion: Start 150 mg daily, may increase to 300 mg daily after one week 4, 5

Escitalopram: Start 10 mg daily, may increase to 20 mg daily if needed 10

When Neither is Clearly Superior

If no specific contraindications or compelling clinical features exist, consider cost and patient preference 1, 2. Both medications require at least 4 months of treatment for a first depressive episode, with longer duration for recurrent depression 2.

The most recent high-quality evidence (2024) confirms equivalent efficacy with the primary differentiator being sexual dysfunction rates favoring bupropion 6, 3.

Related Questions

In an adult female patient on bupropion (Wellbutrin) for depression and attention‑deficit symptoms who has been stable for several months but now presents with insomnia and increased irritability, what is the appropriate next management step?
Does bupropion (Wellbutrin) improve mood and reduce anger?
Should I add escitalopram (Lexapro) to my current bupropion regimen for anxiety, and what is the appropriate starting dose?
What is the appropriate initiation, titration, and monitoring plan for bupropion maintenance therapy in a 27-year-old woman with mixed anxiety and depressive disorder?
A patient has been taking escitalopram (Lexapro) 10 mg daily since [date] and added bupropion (Wellbutrin) 150 mg daily three months later to combat fatigue, tiredness, and perceived increased laziness and homeboundness; after 4–5 years of this combination she now reports anhedonia. What alternative therapies and tapering strategies should be considered, and is continuing bupropion appropriate given that escitalopram may have been an unsuitable initial choice?
Are patients with end‑stage renal disease (ESRD) considered immunocompromised?
What is the appropriate management of respiratory bronchiolitis obliterans?
Should an infectious disease (ID) consultation be obtained for a patient with confirmed Group A Streptococcus bacteremia who is already receiving ceftriaxone?
What is the appropriate dosing regimen for topical corticosteroid cream in eczema?
What is the recommended evaluation and management for obstructive sleep apnea in a pediatric patient?
How should methimazole be restarted in a patient with a free T4 of 12.5 µg/dL?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.